Back Pain, Low: Clinical Trials

2 trials for Back Pain, Low, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Terminated 1

Follow Back Pain, Low: new trials by email Literature Review of Back Pain, Low trials Research Report on Back Pain, Low

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Duloxetine for LBP
Naproxen, Duloxetine - Back Pain, Low
Phase 4RecruitingMontefiore Medical Center1202023-10-042025-12-02
Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
Cannabidiol - Back Pain, Low
Phase 4TerminatedMassachusetts General Hospital72019-11-132022-05-04

Narrower conditions

Low Back Pain (2)

Broader conditions

Back Pain (2)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Cannabidiol (1)  ·  Duloxetine Hydrochloride (1)  ·  Naproxen (1)

Sponsors

Massachusetts General Hospital (1)  ·  Montefiore Medical Center (1)

Countries

United States (2)

Top investigators

Benjamin Friedman, MD (1)  ·  Jodi Gilman, PhD (1)

NIH funding

2023 (1)